Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

254 ARTÍCULOS , VIENDO DEL 226 AL 240

The Impact of Systemic Inflammation on Alzheimer's Disease Pathology

Xie J, Van Hoecke L, Vandenbroucke RE.

Front Immunol. 2022 Jan 6;12:796867. doi: 10.3389/fimmu.2021.796867. eCollection 2021.

Diabetes and cognitive decline

Bellia C, Lombardo M, Meloni M, Della-Morte D, Bellia A, Lauro D.

Adv Clin Chem. 2022;108:37-71. doi: 10.1016/bs.acc.2021.07.006. Epub 2021 Aug 23.

Pharmacogenetic studies in Alzheimer disease

Zúñiga Santamaría T, Yescas Gómez P, Fricke Galindo I, González González M, Ortega Vázquez A, López López M.

Neurologia (Engl Ed). 2022 May;37(4):287-303. doi: 10.1016/j.nrleng.2018.03.022. Epub 2020 Jun 1.

Inflammation in dementia with Lewy bodies

Amin J, Erskine D, Donaghy PC, Surendranathan A, Swann P, Kunicki AP, Boche D, Holmes C, McKeith IG, O'Brien JT, Teeling JL, Thomas AJ.

Neurobiol Dis. 2022 Jun 15;168:105698. doi: 10.1016/j.nbd.2022.105698. Epub 2022 Mar 18.

Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

Roy B, Lee E, Li T, Rampersaud M.

Genes (Basel). 2022 Feb 25;13(3):425. doi: 10.3390/genes13030425.

Sleep apnea and the risk of dementia: A systematic review and meta-analysis

Guay-Gagnon M, Vat S, Forget MF, Tremblay-Gravel M, Ducharme S, Nguyen QD, Desmarais P.

J Sleep Res. 2022 Oct;31(5):e13589. doi: 10.1111/jsr.13589. Epub 2022 Apr 2.

Potential Protein Blood-based Biomarkers in Different Types of Dementia: A Therapeutic Overview

Manzine PR, Vatanabe IP, Grigoli MM, Pedroso RV, Monteiro MPAO, Oliveira DSMS, Nascimento CMC, Peron R, Orlandi FS, Cominetti MR.

Curr Pharm Des. 2022;28(14):1170-1186. doi: 10.2174/1381612828666220408124809.

Biomarkers and diagnosis of dementia with Lewy bodies including prodromal: Practical aspects

Blanc F, Bousiges O.

Rev Neurol (Paris). 2022 May;178(5):472-483. doi: 10.1016/j.neurol.2022.03.008. Epub 2022 Apr 28.

Diagnostic accuracy of keystroke dynamics as digital biomarkers for fine motor decline in neuropsychiatric disorders: a systematic review and meta-analysis

Alfalahi H, Khandoker AH, Chowdhury N, Iakovakis D, Dias SB, Chaudhuri KR, Hadjileontiadis LJ.

Sci Rep. 2022 May 11;12(1):7690. doi: 10.1038/s41598-022-11865-7.

The role of basket trials in drug development for neurodegenerative disorders

Cummings J, Montes A, Kamboj S, Cacho JF.

Alzheimers Res Ther. 2022 May 25;14(1):73. doi: 10.1186/s13195-022-01015-6.

The promise of amplification assays for accurate early detection of α-synucleinopathies: A review

Kurapova R, Chouliaras L, O'Brien JT.

Exp Gerontol. 2022 Aug;165:111842. doi: 10.1016/j.exger.2022.111842. Epub 2022 May 24.

A Prospective Viewpoint on Neurological Diseases and Their Biomarkers

Zehravi M, Kabir J, Akter R, Malik S, Ashraf GM, Tagde P, Ramproshad S, Mondal B, Rahman MH, Mohan AG, Cavalu S.

Molecules. 2022 May 30;27(11):3516. doi: 10.3390/molecules27113516.

Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis

Wong YY, Wu CY, Yu D, Kim E, Wong M, Elez R, Zebarth J, Ouk M, Tan J, Liao J, Haydarian E, Li S, Fang Y, Li P, Pakosh M, Tartaglia MC, Masellis M, Swardfager W.

Parkinsonism Relat Disord. 2022 Aug;101:119-128. doi: 10.1016/j.parkreldis.2022.06.004. Epub 2022 Jun 20.

Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review)

Król-Grzymała A, Sienkiewicz-Szłapka E, Fiedorowicz E, Rozmus D, Cieślińska A, Grzybowski A.

Int J Mol Sci. 2022 Sep 4;23(17):10123. doi: 10.3390/ijms231710123.

Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids

Vaz M, Soares Martins T, Henriques AG.

J Neurochem. 2022 Nov;163(4):266-309. doi: 10.1111/jnc.15697. Epub 2022 Oct 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias